Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Bullboard Posts
Post by GoneBrokeon Jul 17, 2019 4:52pm
165 Views
Post# 29931719

The Up-List Excuse

The Up-List Excuse I'm a little tired of the up-list being used as an excuse to not reveal any news about buildout info , harvest totals and revenue from the harvests now that we have the Hugely anticipated sales license ; all because we are in this " Quiet Period " 

All FSD needs to be quiet about is there anticipated up-list to NYSE not about the number of harvests that have been completed or the projected revenue from the completed harvests .

I've said it before ... it is like FSD Pharma wants the share price to continue to drop so that they can get the outstanding shares to be much lowerer after the reverse split ( don't forget the NYSE is in American dollars and it will eat up a lot of our shares to get to $ 4 american) This is on purpose so they will be able to re-lease more shares ( refinance after the uplist ) in order to finance the clinical drug trials and further buildout. ( as Graham B. eluded to on his last post )

I'm interested to know what the agreement is with Canerra and the 110,000 sq. ft. of grow space that FSD Pharma is supposed to be leasing because that grow space should be about ready to come on line sometime very soon .

It really sucks that FSD Pharma has all of us invested ( myself , sadly very heavily ) in the dark and relying on posts on FaceBook and this message board ... I find this extremely unprofessional ; not to mention their videos repeat the same old mantra and reveal nothing ... There isn't ever any information relating to the amount of bud that has been grown to date in the 20,000 -25,000sq.ft. of grow space available in Cobourg ... It just shouts out very loudly that there really isn't any revevant news to report as BigMac has pointed out recently.

The last thing I'd like to mention is that Dr. Raza mentions the fact that we are in a Quiet period for the up-list in his recent interview video ?? ... I was under the impression that the company isn't supposed the mention anything about the up-list during the Quiet period ??
Bullboard Posts